期刊
LIVER INTERNATIONAL
卷 35, 期 9, 页码 2139-2146出版社
WILEY
DOI: 10.1111/liv.12840
关键词
hepatic steatosis; NAFLD; NASH; Obesity; steatohepatitis
资金
- Burroughs Wellcome Fund
- American Diabetes Association [1-08-CR-08]
- VA Merit Award [1 I01 CX000167-01]
Background & AimsLiver ultrasound (US) is usually used in the clinical setting for the diagnosis and follow-up of patients with nonalcoholic fatty liver disease (NAFLD). However, no large study has carefully assessed its performance using a semiquantitative ultrasonographic scoring system in overweight/obese patients, in comparison to magnetic resonance spectroscopy (H-1-MRS) and histology. MethodsWe recruited 146 patients and performed: a liver US using a 5-parameter scoring system, a liver H-1-MRS to quantify liver fat content, and a liver biopsy to assess histology. All measurements were repeated in a subgroup of patients (n=62) after 18months of follow-up. ResultsThe performance of liver US (parenchymal echo alone) was rather modest, and significantly worse than H-1-MRS (AUROC: 0.82 [0.69-0.94] vs. 0.96 [0.90-1.00]; P=0.04). However, the AUROC improved when different echographic parameters were taken into account (AUROC: 0.89 [0.83-0.96], P=0.15 against H-1-MRS). Optimum sensitivity for liver US was achieved at a liver fat content 12.5%, suggesting that below this threshold, liver US is less sensitive. Liver H-1-MRS showed a high accuracy for the diagnosis of NAFLD, and correlated strongly with histological steatosis (r=0.73, P<0.0001). None of the imaging tests was adequate enough to predict changes over time in histology. ConclusionsDespite its widespread use, liver US has several important limitations that healthcare providers should recognize, particularly because of its low sensitivity. Using a combination of echographic parameters, liver US showed a significant improvement in its diagnostic performance, but still was of limited value for monitoring treatment over time.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据